MONTVALE, N.J., June 8 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) today announced that Jim Sulat, President and Chief
Executive Officer, will provide a company update at the Needham & Company
Fifth Annual BioTechnology and Medical Technology Conference on Wednesday,
June 14, 2006, at 11:00 a.m. EDT at The New York Palace Hotel in New York
City.
Interested parties may access a live webcast of the presentation by
visiting the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. An archived version of the webcast will be
available at the same location through June 21, 2006.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 06/08/2006
/CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;
Laura Perry, Stern Investor Relations, Inc., +1-212-362-1200/
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey, New York
IN: BIO MTC HEA
SU: TDS
MC
-- NYTH096 --
8973 06/08/2006 10:21 EDT http://www.prnewswire.com
